Back

CovationBio starts 50,000-ton Xatryx production, unveils bio-based insole

Verifying
  • CovationBio began commercial production of Xatryx.T bioTHF and Xatryx® bioPTMEG in Qidong.
  • The facility has annual capacity of 50,000 tons for CovationBio’s C4 platform technology.
  • CovationBio and INSITE® will present a partially bio-based sports insole Sept. 2-3, 2026.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.